Elizabeth Holmes Documentary Opens in Theaters, Drawing Audiences and Divided Reviews

You Can See Everything follows Elizabeth Holmes during her last days of freedom before being sent to prison for fraud, according to Mashable Tech. The A24 documentary, directed by Nathan Fielder and Lance Oppenheim, is now in theaters, Business Insider reported on October 16.

Its background is the promise that made Theranos famous. Holmes offered bloodwork performed by a countertop-sized machine using a single droplet from a finger, as Reason described in its review. The film returns to Holmes herself, with coverage examining both her public image and the filmmakers' approach to portraying her.

On October 16, IndieWire Movies reported that the documentary had earned $1.75 million in Thursday previews. Its projected opening was $7 million to $8 million, an early sign of substantial audience interest rather than a confirmed weekend result.

The same day, Holmes' partner Billy Evans publicly defended their participation. Appearing on the All-In podcast, Evans acknowledged that the trailer made Holmes look bad but urged viewers to make up their own minds, according to Variety Movies.

Reviews published on October 16 took markedly different approaches. Reason called the documentary an act of radical empathy. A reviewer at Business Insider focused instead on how unsettling it was to want to believe Holmes, while TechCrunch examined authenticity and the interaction between Holmes and Fielder.

By October 17, attention had spread beyond the film's theatrical audience. Business Insider reported that technology companies and venture capital firms were hosting private screenings, including one organized by Extend at AMC Lincoln Square.

Other accounts of Holmes were also drawing interest. Forbes reported on October 17 that engagement with Hulu's The Dropout and John Carreyrou's book Bad Blood had surged ahead of the documentary's release.

The documentary is in theatrical release, with early ticket sales providing a firmer measure of its reception than the sharply differing reviews. The $1.75 million preview figure reported by IndieWire Movies is an actual result; the $7 million to $8 million opening remains a projection in the supplied coverage.

The discussion also extends to earlier portrayals of Holmes. On October 17, /Film reported that the documentary shows her watching and reacting to Amanda Seyfried's portrayal in The Dropout. That adds another layer to a release already prompting debate about how Holmes presents herself and how the filmmakers present her.

The next concrete measure is the completed opening weekend box office, which will show whether the film meets the projection reported by IndieWire Movies. That result should help distinguish strong preview interest from a sustained theatrical audience.